醫藥和生物技術領域的合作開發協議（2016-2026）

建立更強大的合作夥伴關係—探索全球生物製藥產業的合作開發模式、合約條款和承包商趨勢

"醫藥和生物技術領域的合作開發協議（2016-2026）" 報告對生命科學領域的合作開發協議進行了最全面的分析。本報告涵蓋近十年的活動，提供豐富的數據洞察，深入分析企業如何共同開發候選藥物、分擔開發風險以及協調商業化責任。

本次全面修訂版分析了實際的合作開發協議，包括財務條款、合作策略，以及（如有）向美國證券交易委員會 (SEC) 提交的合約文件的連結。

免費報告樣本

主要特點和優勢

• 涵蓋 2016 年至 2026 年的合約

追蹤合作開發協議的演變並識別策略模式。

• 合約結構與條款分析

了解合作開發協議的架構－每家公司的貢獻、風險分擔方式、利潤分配方式。

• 自信地比較財務指標

查看關鍵金額、里程碑付款、股權比例等，以幫助您建立自己的合約模型。

• 取得實際合約文本

如果可以，請查閱實際提交的合同，以深入了解合同條款、定義和觸發條件。

• 辨識最活躍的參與者

識別簽署聯合開發協議的前 25 家公司，並了解它們不同的方法。

目錄 - 章節架構

第一章：引言

概述共同開發協議、公司選擇此模式的原因以及本報告的結構。

第二章：共同開發活動的趨勢

依年份、產業、治療領域和地區對聯合開發協議進行視覺化和描述性分析。

第三章：合約結構與關鍵條款

分析公司如何分享智慧財產權、開發責任、成本和商業化權利。

第四章：高價值聯合開發協議

依揭露金額順序介紹關鍵協議。包括財務條款、策略依據以及公開的原始協議連結。

第五章：25 家活躍的合作開發協議公司

公司簡介，包括每家公司的合約歷史和合作模式。也提供每家公司完整合約記錄的連結。

第六章：綜合合約目錄

合作開發協議詳細索引（依以下方式組織）：

• 公司名稱（依字母順序排列）
• 治療領域
• 技術類型
• 合約類型
• 每筆記錄都連結到“目前合約資料庫”，其中也提供合約文件。
• 本報告的目標讀者是誰？
• 業務拓展和授權專業人士 - 評估成功交易的結構、條款和合作夥伴角色。
• 主管與投資人 - 了解合作開發如何協助加速產品研發進程並降低資本消耗。
• 法律和合約經理 - 參考實際合約條款和交易機制，幫助您起草自己的條款和條件。
• 商業和策略規劃人員 - 了解合作開發夥伴之間如何分配權利、責任和利益。
• 本報告的重要性
• 隨著研發成本的上升和研發週期的縮短，合作開發協議提供了一種極具吸引力的解決方案，能夠實現風險共擔、激勵機制的協調以及快速執行。本報告將幫助您了解市場標準條款、可協商要素以及領先企業在合作研發夥伴關係中取得成功的策略。
• 從真實的合約案例中學習，掌握產業領導者的合作方法，並建立更牢固的夥伴關係。立即訂購 "2016-2026 年醫藥與生技合作開發協議" 。

目錄

摘要整理

第一章：引言

第二章：聯合開發交易趨勢

• 引言
• 聯合開發協議的定義
• 2016年以來聯合開發協議的趨勢
  • 聯合開發交易年度趨勢（2016-2026）
  • 依開發階段劃分的共同開發交易（2016-2026）
  • 依產業劃分的共同開發交易（2016-2026）
  • 依治療領域劃分的共同開發交易（2016-2026）
  • 依技術類型劃分的共同開發交易（2016-2026）
  • 依最活躍公司劃分的共同開發交易（2016-2026）
• 簽訂聯合開發夥伴關係協議的原因
• 聯合開發協議的未來

第三章 合作開發協議結構概述

• 引言
• 合作開發協議的結構

第四章 - 領先的合作開發協議

• 引言
• 以價值排名的頂級合作開發交易

第五章 - 最活躍的25位合作開發交易撮合者

• 引言
• 最活躍的25位合作開發交易撮合者

第六章 - 包含交易的合作開發協議目錄

• 簡介
• 2016年至2026年依交易類型劃分的合作開發協議
• 交易目錄
• 依公司劃分的合作開發交易目錄 (AZ)
• 依治療領域劃分的合作開發交易目錄
• 以技術類型劃分的共同開發交易目錄
• 關於研究公司
• 當前合作夥伴關係
• 當前協議
• 近期合作報告標題

Power Smarter Partnerships: Explore Co-development Models, Terms, and Dealmakers Across the Global Biopharma Landscape

The Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 report delivers the most comprehensive analysis of collaborative development agreements in the life sciences sector. Spanning nearly a decade of activity, the report provides a data-rich view into how companies co-develop drug candidates, share development risk, and align commercialization responsibilities.

This fully updated edition explores real-world co-development deals and includes financial terms, partnering strategies, and links to actual SEC-filed contract documents where available.

Free report sample

Key Features & Benefits

• Covers Deals from 2016 to 2026

Track the evolution of co-development dealmaking and identify strategic patterns.

• Analyze Deal Structures and Terms

Understand how co-development deals are structured-who contributes what, how risks are shared, and how profits are split.

• Benchmark Financials with Confidence

Review headline values, milestone payments, and equity contributions to support your own deal modeling.

• Access Real Contract Language

Where available, examine actual contract filings to gain insight into deal clauses, definitions, and triggers.

• Spot the Most Active Players

Identify the top 25 companies engaging in co-development deals-and learn what differentiates their approach.

What's Inside - Chapter Breakdown

Chapter 1: Introduction

An overview of co-development dealmaking, why companies choose this model, and how this report is structured.

Chapter 2: Trends in Co-development Activity

Visual and narrative analysis of co-development deals by year, sector, therapeutic area, and region.

Chapter 3: Deal Structures & Key Clauses

Breaks down how companies share IP, development responsibilities, costs, and commercialization rights.

Chapter 4: High-Value Co-development Deals

Profiles of major deals sorted by disclosed value. Includes financial terms, strategic rationale, and links to original contracts where publicly available.

Chapter 5: Top 25 Active Co-development Dealmakers

Company profiles with deal histories and partnership approaches-including links to each company's full deal records.

Chapter 6: Comprehensive Deal Directory

Detailed index of co-development deals organized by:

• Company A-Z
• Therapy area
• Technology type
• Deal type
• Each record links to the Current Agreements database, with contract documents where available.
• Who Should Use This Report?
• Business Development & Licensing Professionals - Evaluate structures, terms, and partner roles across successful deals.
• C-Level Executives & Investors - Understand how collaborative development can accelerate product pipelines and reduce burn.
• Legal & Contract Managers - Benchmark real-world clauses and deal mechanics to guide your own term sheets.
• Commercial & Strategic Planners - Learn how rights, responsibilities, and revenues are allocated across co-development partners.
• Why This Report Matters
• As development costs rise and timelines tighten, co-development deals offer a compelling solution-shared risk, aligned incentives, and faster execution. This report helps you understand what's market standard, what's negotiable, and what leading companies are doing to succeed in shared R&D partnerships.
• Learn from real deals. See how the leaders collaborate. Build stronger partnerships. Order your copy of Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 today.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-development dealmaking

• 2.1. Introduction
• 2.2. Definition of co-development deal
• 2.3. Trends in co-development deals since 2016
  • 2.3.1. Co-development dealmaking by year, 2016-2026
  • 2.3.2. Co-development dealmaking by phase of development, 2016-2026
  • 2.3.3. Co-development dealmaking by industry sector, 2016-2026
  • 2.3.4. Co-development dealmaking by therapy area, 2016-2026
  • 2.3.5. Co-development dealmaking by technology type, 2016-2026
  • 2.3.6. Co-development dealmaking by most active company, 2016-2026
• 2.4. Reasons for entering into co-development partnering deals
• 2.5. The future of co-development deals

Chapter 3 - Overview of co-development deal structure

• 3.1. Introduction
• 3.2. Co-development agreement structure

Chapter 4 - Leading co-development deals

• 4.1. Introduction
• 4.2. Top co-development deals by value

Chapter 5 - Top 25 most active co-development dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-development dealmakers

Chapter 6 - Co-development deals including contracts directory

• 6.1. Introduction
• 6.2. Co-development deals with contracts 2016-2026
• Deal directory
• Deal directory - co-development dealmaking by companies A-Z
• Deal directory - co-development dealmaking by therapy area
• Deal directory - co-development dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-development deal
• Figure 2: Trends in co-development deal announcements, 2016-2026
• Figure 3: Co-development deals signed at each phase of development, 2016-2026
• Figure 4: Co-development deals by industry sector, 2016-2026
• Figure 5: Co-development deals by therapy area, 2016-2026
• Figure 6: Co-development deals by technology type, 2016-2026
• Figure 7: Top 25 most active co-development dealmakers, 2016-2026
• Figure 8: Top co-development deals by value, 2016-2026
• Figure 9: Most active co-development dealmakers, 2016-2026